Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware

Numerous clinical studies have indicated that elevated FGF23 (fibroblast growth factor 23) levels may be associated with cardiovascular (CV) mortality, especially in patients with chronic kidney disease. The purpose of this study was to examine the hypothesis that FGF23 may be a potent CV risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurpas, Anna, Supel, Karolina, Wieczorkiewicz, Paulina, Bodalska Duleba, Joanna, Zielinska, Marzenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254740/
https://www.ncbi.nlm.nih.gov/pubmed/35736431
http://dx.doi.org/10.3390/metabo12060498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254740/
https://www.ncbi.nlm.nih.gov/pubmed/35736431
http://dx.doi.org/10.3390/metabo12060498

Ejemplares similares